Claude AI helped boost cancer-fighting immune cells in lab tests

Anthropic's October 27 drug-development update covers six partners using Claude. Generate Biomedicines shortened a CAR-T receptor's signaling segment from 154 to 45 amino acids, and the engineered cells kept killing over 90% of H929 myeloma cells through day 13.

• Compact receptor produced 8.4 times the surface density of the reference design
• Reference cells had lost most killing activity by day nine
• Enveda: reviewing four records took 166 minutes versus 1,553 manually
• Mithril: antibody gave mice 1.95 times the peak forelimb force